SCHEDULE 13D

Company

TherapeuticsMD, Inc.

Filed

April 17, 2012

Accession Number

0001387131-12-001211

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →